Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 2
2011 2
2012 4
2014 4
2015 3
2016 2
2017 5
2018 2
2019 2
2020 4
2021 1
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability.
Mircetic J, Camgöz A, Abohawya M, Ding L, Dietzel J, Tobar SG, Paszkowski-Rogacz M, Seidlitz T, Schmäche T, Mehnert MC, Sidorova O, Weitz J, Buchholz F, Stange DE. Mircetic J, et al. Among authors: paszkowski rogacz m. Small Methods. 2023 Jun;7(6):e2201605. doi: 10.1002/smtd.202201605. Epub 2023 Mar 12. Small Methods. 2023. PMID: 36908010
Precise excision of HTLV-1 provirus with a designer-recombinase.
Rojo-Romanos T, Karpinski J, Millen S, Beschorner N, Simon F, Paszkowski-Rogacz M, Lansing F, Schneider PM, Sonntag J, Hauber J, Thoma-Kress AK, Buchholz F. Rojo-Romanos T, et al. Among authors: paszkowski rogacz m. Mol Ther. 2023 Jul 5;31(7):2266-2285. doi: 10.1016/j.ymthe.2023.03.014. Epub 2023 Mar 17. Mol Ther. 2023. PMID: 36934299 Free article.
Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.
Gebler C, Lohoff T, Paszkowski-Rogacz M, Mircetic J, Chakraborty D, Camgoz A, Hamann MV, Theis M, Thiede C, Buchholz F. Gebler C, et al. Among authors: paszkowski rogacz m. J Natl Cancer Inst. 2016 Aug 30;109(1):djw183. doi: 10.1093/jnci/djw183. Print 2017 Jan. J Natl Cancer Inst. 2016. PMID: 27576906 Free PMC article.
Correction of a Factor VIII genomic inversion with designer-recombinases.
Lansing F, Mukhametzyanova L, Rojo-Romanos T, Iwasawa K, Kimura M, Paszkowski-Rogacz M, Karpinski J, Grass T, Sonntag J, Schneider PM, Günes C, Hoersten J, Schmitt LT, Rodriguez-Muela N, Knöfler R, Takebe T, Buchholz F. Lansing F, et al. Among authors: paszkowski rogacz m. Nat Commun. 2022 Jan 20;13(1):422. doi: 10.1038/s41467-022-28080-7. Nat Commun. 2022. PMID: 35058465 Free PMC article.
Phylointeractomics reconstructs functional evolution of protein binding.
Kappei D, Scheibe M, Paszkowski-Rogacz M, Bluhm A, Gossmann TI, Dietz S, Dejung M, Herlyn H, Buchholz F, Mann M, Butter F. Kappei D, et al. Among authors: paszkowski rogacz m. Nat Commun. 2017 Feb 8;8:14334. doi: 10.1038/ncomms14334. Nat Commun. 2017. PMID: 28176777 Free PMC article.
From RNAi screens to molecular function in embryonic stem cells.
Ding L, Poser I, Paszkowski-Rogacz M, Buchholz F. Ding L, et al. Among authors: paszkowski rogacz m. Stem Cell Rev Rep. 2012 Mar;8(1):32-42. doi: 10.1007/s12015-011-9269-z. Stem Cell Rev Rep. 2012. PMID: 21526416 Free PMC article. Review.
CRISPR/Cas9 as a tool to dissect cancer mutations.
Sayed S, Paszkowski-Rogacz M, Schmitt LT, Buchholz F. Sayed S, et al. Among authors: paszkowski rogacz m. Methods. 2019 Jul 15;164-165:36-48. doi: 10.1016/j.ymeth.2019.05.007. Epub 2019 May 10. Methods. 2019. PMID: 31078796 Free article.
Multipose binding in molecular docking.
Atkovska K, Samsonov SA, Paszkowski-Rogacz M, Pisabarro MT. Atkovska K, et al. Among authors: paszkowski rogacz m. Int J Mol Sci. 2014 Feb 14;15(2):2622-45. doi: 10.3390/ijms15022622. Int J Mol Sci. 2014. PMID: 24534807 Free PMC article.
41 results